What The Inflation Reduction Act’s Reforms To Medicare Part D Mean For Prescription Drug Prices

Back to Resources
ATINews
01/26/2023
AUTHOR – ATI Advisory

Anna Kaltenboeck recently penned a Health Affairs article that explains how the Inflation Reduction Act will affect Medicare Part D and prescription drug pricing.

Recent News

News

Uncle Sam Wants You—to Fight High Drug Prices

Anna Kaltenboeck discusses staffing at the Centers for Medicare and Medicaid Services' in respect to their prescription drug reimbursement team with the Wall Street Journal.
Read More Read More
News

NEW DATA SHOWS RACIAL AND ETHNIC DISPARITIES FOR MEDICARE BENEFICIARIES WHO HAVE DIFFICULTY WITH ACTIVITIES OF DAILY LIVING

Community-dwelling Medicare beneficiaries who are Black and/or Latino/a are more likely than white beneficiaries to report difficulty managing activities of daily living, according to a databook released by ATI Advisory (ATI) with support from the Robert Wood Johnson Foundation (RWJF). Activities of daily living include dressing, bathing, walking across the room, transferring in and out of bed or chair, using the toilet, and eating.
Read More Read More
News

New Medicare Proposal Would Cover Training for Family Caregivers

CEO Anne Tumlinson comments to U.S. News & World Report about a proposal from the Centers for Medicare and Medicaid Services that would reimburse health professionals to train family caregivers.
Read More Read More
See more News
Share
LinkedIn / /